Wolverine Asset Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Wolverine Asset Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.58K	Hold	147,101	–	–	﹤0.01%	1507
2026 Q1	$2.68K	Hold	147,101	–	–	﹤0.01%	1533
2025 Q4	$2.72K	Hold	147,101	–	–	﹤0.01%	1522
2025 Q3	$3.71K	Hold	147,101	–	–	﹤0.01%	1452
2025 Q2	$2.99K	Hold	147,101	–	–	﹤0.01%	1458
2025 Q1	$2.49K	Hold	147,101	–	–	﹤0.01%	1418
2024 Q4	$2.12K	Hold	147,101	–	–	﹤0.01%	1478
2024 Q3	$1.85K	Hold	147,101	–	–	﹤0.01%	1482
2024 Q2	$1.54K	Buy	147,101 +12,184	+9%	+$677	﹤0.01%	1511
2024 Q1	$9.44K	Buy	+134,917	New	+$8.4K	﹤0.01%	1305

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wolverine Asset Management's PBMWW Position: Q2 2026 in Review

Wolverine Asset Management held its Psyence Biomedical Warrant (PBMWW) position steady in Q2 2026 at 147,101 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Wolverine Asset Management first reported a position in PBMWW in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.44K in Q1 2024. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

Wolverine Asset Management held 147,101 shares of Psyence Biomedical Warrant worth $3.58K as of Q2 2026.
Wolverine Asset Management left its Psyence Biomedical Warrant share count unchanged in Q2 2026.
Psyence Biomedical Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1507 holding.
Wolverine Asset Management first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 10 quarters since.
Wolverine Asset Management's Psyence Biomedical Warrant position peaked at $9.44K in Q1 2024.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.